The discovery of a novel orally available CCR5 antagonist, as a therapeutic for HIV-1 infection

被引：0

作者：

Nogi, Rena Nishizawa

Nishiyama, Toshihiko

Hisaichi, Katsuya

Minamoto, Chiaki

Matsunaga, Naoki

Hirai, Keisuke

Habashita, Hiromu

Takaoka, Yoshikazu

Toda, Masaaki

Takahashi, Eiji

Imawaka, Haruo

Sagawa, Kenji

Shibayama, Shiro

Fukushima, Daikichi

Maeda, Kenji

Mitsuya, Hiroaki

机构：

[1] ONO PHARMACEUT CO LTD, Dept Med Chem, Mishima, Osaka 6188585, Japan

[2] ONO PHARMACEUT CO LTD, Pharmacokinet Res Labs, Mishima, Osaka 6188585, Japan

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2006年 / 231卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

385-MEDI

引用

页数：1

共 50 条

[41] Inhibition of HIV-1 infection by synthetic peptides derived CCR5 fragments [J].

Imai, Masaki ;

Baranyi, Lajos ;

Okada, Noriko ;

Okada, Hidechika .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2007, 353 (04) :851-856

[42] Prognostic Value of a CCR5 Defective Allele in Pediatric HIV-1 Infection [J].

Maria Luisa Romiti ;

Claudia Colognesi ;

Caterina Cancrini ;

Antonio Mas ;

Monica Berrino ;

Francesca Salvatori ;

Paola Orlandi ;

Marianne Jansson ;

Elvia Palomba ;

Anna Plebani ;

Jose M. Bertran ;

Manuel Hernandez ;

Maurizio de Martino ;

Antonio Amoroso ;

Pier Angelo Tovo ;

Paolo Rossi ;

Teresa Espanol ;

Gabriella Scarlatti .

Molecular Medicine, 2000, 6 :28-36

[43] Relationship between productive HIV-1 infection of macrophages and CCR5 utilization [J].

Hung, CS ;

Pontow, S ;

Ratner, L .

VIROLOGY, 1999, 264 (02) :278-288

[44] CCR5 genotype and HIV-1 infection in perinatally-exposed infants [J].

Mas, A ;

Español, T ;

Heredia, A ;

Pedraza, MA ;

Hernandez, M ;

Caragol, I ;

Fernando, M ;

Bertran, JM ;

Alcami, J ;

Soriano, V .

JOURNAL OF INFECTION, 1999, 38 (01) :9-11

[45] Polymorphism in the CCR5 gene promoter and HIV-1 infection in North Indians [J].

Kaur, Gurvinder ;

Singh, P. ;

Rapthap, C. C. ;

Kumar, N. ;

Vajpayee, M. ;

Sharma, S. K. ;

Wanchu, A. ;

Mehra, N. K. .

HUMAN IMMUNOLOGY, 2007, 68 (05) :454-461

[46] Association between CCR5 genotype and the clinical course of HIV-1 infection [J].

Husman, AMD ;

Koot, M ;

Cornelissen, M ;

Keet, IPM ;

Brouwer, M ;

Broersen, SM ;

Bakker, M ;

Roos, MTL ;

Prins, M ;

deWolf, F ;

Coutinho, RA ;

Miedema, F ;

Goudsmit, J ;

Schuitemaker, H .

ANNALS OF INTERNAL MEDICINE, 1997, 127 (10) :882-+

[47] Prognostic value of a CCR5 defective allele in pediatric HIV-1 infection [J].

Romiti, ML ;

Colognesi, C ;

Cancrini, C ;

Mas, A ;

Berrino, M ;

Salvatori, F ;

Orlandi, P ;

Jansson, M ;

Palomba, E ;

Plebani, A ;

Bertran, JM ;

Hernandez, M ;

de Martino, M ;

Amoroso, A ;

Tovo, PA ;

Rossi, P ;

Espanol, T ;

Scarlatti, G .

MOLECULAR MEDICINE, 2000, 6 (01) :28-36

[48] Discovery of potent, orally bioavailable CCR5 antagonists - 1. [J].

Tagat, J ;

Nazareno, D ;

Vice, S ;

Lin, S ;

Steensma, R ;

Miller, M ;

Bauer, A ;

McCombie, S ;

Palani, A ;

Josien, H ;

Clader, J ;

Neustadt, B ;

Greenlee, W ;

Ganguly, A ;

Piwinski, J ;

Chan, TM ;

Evans, A ;

Dan, N ;

Baroudy, B ;

Endres, M ;

Strizki, J ;

Vantuno, N ;

Cox, K ;

Broske, L ;

Zhang, X .

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 :U5-U5

[49] Vicriviroc, a CCR5 receptor antagonist for the potential treatment of HIV infection [J].

Klibanov, Olga M. .

CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2009, 10 (08) :845-859

[50] Novel interfering bifunctional molecules against the CCR5 coreceptor are efficient inhibitors of HIV-1 infection [J].

Abad, JL ;

González, MA ;

del Real, G ;

Mira, E ;

Mañes, S ;

Serrano, F ;

Bernad, A .

MOLECULAR THERAPY, 2003, 8 (03) :475-484

← 1 2 3 4 5 →